Persistent Asthma

17 registered clinical trials studyying Persistent Asthma.

Status	Trial	Sponsor	Phase
Unknown	Indoor Air Quality Asthma Study: The Effect of Indoor Air Quality and Mitigation of Same on Persistent Asthma NCT05843045	Dayton Children's Hospital	N/A
Withdrawn	Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma P NCT04271839	Mundipharma Pharmaceuticals S.L.	Phase 4
Completed	Cockroach Immunotherapy in Children and Adolescents NCT03541187	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2
Active Not Recruiting	Asthma Research in Children and Adolescents NCT04480242	Parc de Salut Mar	—
Unknown	Refractory Asthma Stratification Programme (RASP) Bronchoscopy Study NCT02883530	University of Leicester	—
Completed	Study to Assess the Efficacy and Safety of Beclomethasone Dipropionate in Adolescent and Adult Patients 12 Yea NCT02513160	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 3
Completed	Long-Term Safety Study of Fluticasone Propionate (Fp) Multidose Dry Powder Inhaler (MDPI) and Fluticasone Prop NCT02175771	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 3
Completed	Adolescent Controlled Text Messaging to Improve Asthma Medication Adherence in Primary Care NCT02176694	Children's Hospital Medical Center, Cincinnati	N/A
Unknown	Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital NCT02053402	University of Limpopo	Phase 4
Completed	A 12-week Safety and Efficacy Study of Beclomethasone Dipropionate (80 and 160 mcg/Day) Delivered Via Breath-A NCT02040779	Teva Branded Pharmaceutical Products R&D, Inc.	Phase 3
Completed	Impact of Lung Flute Therapy on Asthma NCT02003521	Medical Acoustics LLC	—
Terminated	Study of Safety of Foradil in Patients With Persistent Asthma NCT01845025	Novartis Pharmaceuticals	Phase 4
Completed	E-nose and Inflammatory Asthma Phenotypes NCT02026336	Astrid Crespo	N/A
Completed	Efficacy, Safety, and Pharmacokinetics of QAW039 NCT01253603	Novartis Pharmaceuticals	Phase 2
Completed	Asthma Control in Elderly Patients With Montelukast NCT01147510	Ajou University School of Medicine	Phase 4
Completed	Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma NCT01078688	AstraZeneca	—
Completed	Efficacy, Safety and Pharmacokinetics of Different Regimens of Indacaterol NCT01156844	Novartis Pharmaceuticals	Phase 2